Analysts from Cantor Fitzgerald have rated AmSurg stock at "buy," according to an Analyst Ratings report.
Cantor Fitzgerald set the company's shares at a price target of $67. AmSurg has a market cap of $2.98 billion.
AmSurg stock rated at 'buy'
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.